AI-Designed Drug Reduces Fentanyl Consumption in Animal Models
A drug designed with AI assistance has shown promise in reducing fentanyl use in preclinical trials by targeting serotonin receptors, marking a concrete step forward for AI in drug discovery.
Subscribe to unlock all stories
Get full access to The Singularity Ledger, archive included.
Cancel anytime. Payments powered by Stripe.